Persistence of Immunogenicity of a Purified Inactivated Zika Virus Vaccine Candidate in Healthy Adults: 2 Years of Follow-up Compared With Natural Infection.
Acosta CJ, Diaz C, Nordio F, Han HH, Moss KJ, Bohning K, Kumar P, Liu M, Patel H, Pacciarini F, Mwangi V, Walter E, Powell TD, El Sahly HM, Baldwin WR, Santangelo J, Anderson EJ, Dubin G.
Acosta CJ, et al. Among authors: moss kj.
J Infect Dis. 2023 May 29;227(11):1303-1312. doi: 10.1093/infdis/jiac482.
J Infect Dis. 2023.
PMID: 36484441
Free PMC article.
Clinical Trial.